Tirmed Pharma
Pre-clinicalOur primary project is a next generation topical treatment of eczema (atopic dermatitis) for mild to moderate symptoms
Founded
2018
Focus
Small Molecules
About
Our primary project is a next generation topical treatment of eczema (atopic dermatitis) for mild to moderate symptoms
Company Info
TypePrivate
Founded2018
LocationStockholm, Sweden
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile